NCT02471963View on ClinicalTrials.gov

Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function

PHASE3CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

June 30, 2016

Conditions
Diabetes Mellitus Type 2
Interventions
DRUG

Empagliflozin

DRUG

Placebo

Trial Locations (1)

91054

University of Erlangen-Nuremberg, Erlangen

All Listed Sponsors
lead

University of Erlangen-Nürnberg Medical School

OTHER

NCT02471963 - Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function | Biotech Hunter | Biotech Hunter